Detalles de la búsqueda
1.
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
Ann Surg Oncol
; 31(6): 3758-3768, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453767
2.
Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
Ann Surg Oncol
; 30(4): 2048-2056, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36566258
3.
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
Thorax
; 77(12): 1260-1267, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35149582
4.
The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 29(9): 5830-5841, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35650370
5.
Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
Ann Surg Oncol
; 29(11): 6566-6576, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35513588
6.
Predictive Ability of C-Reactive Protein in Detecting Short-Term Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cross-Sectional Study.
Ann Surg Oncol
; 28(1): 233-243, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32524458
7.
The Accuracy of the Surgical Peritoneal Cancer Index in Patients with Peritoneal Metastases of Colorectal Cancer.
Dig Surg
; 38(3): 205-211, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657551
8.
Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
Ann Surg Oncol
; 26(13): 4222-4228, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31620941
9.
ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases-A Nationwide Population-Based Study.
Ann Surg Oncol
; 31(7): 4749-4750, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658412
10.
Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial.
BMC Cancer
; 19(1): 254, 2019 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30898098
11.
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
BMC Cancer
; 19(1): 390, 2019 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023318
12.
ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
Ann Surg Oncol
; 30(4): 2057, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36719571
13.
ASO Author Reflections: The Timing of Onset of Peritoneal Metastases from Colorectal Carcinoma Is Not an Independent Predictor of Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 29(11): 6577-6578, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486267
14.
Prognostic Significance of Tumor-Positive Internal Mammary Sentinel Lymph Nodes in Breast Cancer: A Multicenter Cohort Study.
Ann Surg Oncol
; 22(13): 4254-62, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25808100
15.
Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
Clin Exp Med
; 24(1): 80, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642130
16.
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases.
Biomed Pharmacother
; 176: 116820, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38810398
17.
Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Eur J Surg Oncol
; 50(6): 108294, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583215
18.
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
BMJ Open
; 14(1): e077667, 2024 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38238055
19.
Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers.
Eur J Surg Oncol
; 49(3): 611-618, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610896
20.
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37536940